[MS5] Mini Symposium 5
Anaphylaxis

[MS5-6] Assessment of the pharmacokinetics, pharmacodynamics, and safety of low dose intra-nasal epinephrine (ARS-1) with intramuscular by needle-syringe and EpiPen in patients with induced allergic rhinitis

Motohiro Ebisawa¹, Richard E Lowenthal², Sarina Tanimoto² (1.Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Japan, 2.ARS Pharmaceuticals, Inc., USA)